Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385177
Status:
COMPLETED
Last Update Posted:
2009-06-04
First Post:
2006-10-03
Brief Title:
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
Sponsor:
Achieve Life Sciences
Organization:
Achieve Life Sciences
Organization Data
Organization:
Achieve Life Sciences
Class:
INDUSTRY
Study ID:
SON-2310-06-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Achieve Life Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Monica Krieger VP Regulatory Affairs
Old Organization:
OncoGenex Pharmaceuticals